刊名:Journal of Cancer Research and Clinical Oncology
出版年:2007
出版时间:February, 2007
年:2007
卷:133
期:2
页码:93-102
全文大小:525 KB
刊物类别:Medicine
刊物主题:Medicine & Public Health Oncology Cancer Research Internal Medicine Hematology
出版者:Springer Berlin / Heidelberg
ISSN:1432-1335
文摘
Purpose EGFR mutations in lung cancer increase sensitivity to an EGFR tyrosine kinase inhibitor, gefitinib. Mutation analysis of EGFR is essential for prediction of gefitinib response and avoidance of the coincidental severe side effects for the unresponsive population. The purpose of the present study is to apply DHPLC as a screening system of detection of EGFR mutations for large scaled population.